Biotech’s comeback looks built to last
The Wall Street Journal - 13-Oct-2025Easing regulations and new drug approvals fuel optimism for a sustained biotech rally
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
Easing regulations and new drug approvals fuel optimism for a sustained biotech rally
Pharma giant retreats from costly cell therapy deals amid layoffs and R&D cuts
From science to solution, from policy to practice
Focus areas include gene editing, stem cell therapies, and affordable health solutions
A $70m fund takes bold risks to validate ground-breaking ideas and reshape biotech innovation
Click on resource name for more details.
12-Sep-2026
As clinical longevity gains momentum in China, 7th TimePie Longevity Forum spotlights evidence-based medicine (Shanghai)
20-Sep-2025
China's premier annual event organised by TimePie (Shanghai, China)
Inside Tracker Podcast Episode-Karl Pfleger on the Biotech Boom in Aging
No blog posts found!